|
2025
|
Invention
|
Methods of treating cancer.
Disclosed herein are methods of treating cancer by administering a h... |
|
2024
|
Invention
|
Oncolytic immunotherapy by tumor micro-environment remodeling.
The disclosure relates to modifie... |
|
|
Invention
|
Oncolytic viruses for modified mhc expression.
The present disclosure provides for recombinant o... |
|
2023
|
Invention
|
Compositions of cd47/sirp-alpha immune checkpoint inhibitors and uses thereof. The present disclo... |
|
|
Invention
|
Tnfsf-l fusion proteins and uses thereof.
The present disclosure provides for compositions compr... |
|
|
Invention
|
Nucleic acids encoding soluble pd-1 and il-12 and uses thereof. The present disclosure provides f... |
|
|
Invention
|
Nucleic acids encoding tgf-beta inhibitor and il-12 and uses thereof. The present disclosure prov... |
|
|
Invention
|
Nucleic acids encoding tgf-beta inhibitor and il-12 and uses thereof |
|
|
Invention
|
Nucleic acids encoding soluble pd-1 and il-12 and uses thereof |
|
|
Invention
|
Oncolytic viruses for modified mhc expression. The present disclosure provides for recombinant on... |
|
|
Invention
|
Oncolytic immunotherapy by tumor micro-environment remodeling. The disclosure relates to modified... |
|
2022
|
Invention
|
Tnfsf-l fusion proteins and uses thereof. The present disclosure provides for compositions compri... |
|
|
P/S
|
Medical and scientific research in the fields of immunotherapy, immunotherapeutics, biotechnology... |
|
|
P/S
|
Biological preparations for scientific research purposes.
Biological preparations for use in immu... |
|
|
P/S
|
Medical and scientific research in the fields of
immunotherapy, immunotherapeutics, biotechnolog... |
|
|
P/S
|
Biological products for medical and scientific research. Immunotherapeutics; biopharmaceutical pr... |
|
|
Invention
|
Producer viruses for generation of retroviruses in situ.
This disclosure provides compositions c... |
|
|
Invention
|
Platform oncolytic vector for systemic delivery.
This disclosure provides a modified oncolytic v... |
|
2021
|
P/S
|
Biological preparations for scientific research purposes |
|
|
P/S
|
Biological preparations for use in immunotherapy, namely, oncolytic vaccinia viruses; Pharmaceuti... |
|
|
Invention
|
Platform oncolytic vector for systemic delivery. Described herein are modified oncolytic viruses ... |
|
|
Invention
|
Platform oncolytic vector for systemic delivery. This disclosure provides a modified oncolytic vi... |
|
|
Invention
|
Modified extracellular enveloped virus.
This disclosure provides a modified oncolytic poxvirus, ... |
|
|
Invention
|
Manufacture of virus.
Provided herein are methods of manufacturing viruses. Also provided herein... |
|
2020
|
Invention
|
Producer viruses for generation of retroviruses in situ. This disclosure provides compositions co... |
|
|
Invention
|
Modified extracellular enveloped virus. This disclosure provides a modified oncolytic poxvirus, s... |
|
|
Invention
|
Methods of treating cancer. Disclosed herein are methods of treating cancer by administering a he... |
|
2019
|
Invention
|
Manufacture of virus. Provided herein are methods of manufacturing viruses. Also provided herein ... |
